These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
224 related items for PubMed ID: 18525456
21. Long-term outcome after allo-SCT: close follow-up on a large cohort treated with myeloablative regimens. Abou-Mourad YR, Lau BC, Barnett MJ, Forrest DL, Hogge DE, Nantel SH, Nevill TJ, Shepherd JD, Smith CA, Song KW, Sutherland HJ, Toze CL, Lavoie JC. Bone Marrow Transplant; 2010 Feb; 45(2):295-302. PubMed ID: 19597425 [Abstract] [Full Text] [Related]
26. Allogeneic blood stem cell transplantation after a reduced-intensity, preparative regimen: a pilot study in patients with refractory malignancies. Pedrazzoli P, Da Prada GA, Giorgiani G, Schiavo R, Zambelli A, Giraldi E, Landonio G, Locatelli F, Siena S, Della Cuna GR. Cancer; 2002 May 01; 94(9):2409-15. PubMed ID: 12015766 [Abstract] [Full Text] [Related]
27. A prospective study of cognitive function in children receiving whole-brain radiotherapy and chemotherapy: 2-year results. Packer RJ, Sutton LN, Atkins TE, Radcliffe J, Bunin GR, D'Angio G, Siegel KR, Schut L. J Neurosurg; 1989 May 01; 70(5):707-13. PubMed ID: 2709111 [Abstract] [Full Text] [Related]
28. Evaluation of readmission in children receiving allogeneic hematopoietic stem cell transplantation: an institutional experience. Jaing TH, Tsay PK, Yang CP, Hung IJ, Wen YC, Tseng CK. Transplant Proc; 2008 Dec 01; 40(10):3643-5. PubMed ID: 19100457 [Abstract] [Full Text] [Related]
30. Disparity in survival outcome after hematopoietic stem cell transplantation for hematologic malignancies according to area of primary residence. Rao K, Darrington DL, Schumacher JJ, Devetten M, Vose JM, Loberiza FR. Biol Blood Marrow Transplant; 2007 Dec 01; 13(12):1508-14. PubMed ID: 18022581 [Abstract] [Full Text] [Related]
31. Developmental model relating white matter volume to neurocognitive deficits in pediatric brain tumor survivors. Reddick WE, White HA, Glass JO, Wheeler GC, Thompson SJ, Gajjar A, Leigh L, Mulhern RK. Cancer; 2003 May 15; 97(10):2512-9. PubMed ID: 12733151 [Abstract] [Full Text] [Related]
33. Long-term neurocognitive function of pediatric patients with severe combined immune deficiency (SCID): pre- and post-hematopoietic stem cell transplant (HSCT). Lin M, Epport K, Azen C, Parkman R, Kohn DB, Shah AJ. J Clin Immunol; 2009 Mar 15; 29(2):231-7. PubMed ID: 18807155 [Abstract] [Full Text] [Related]
34. Impact of cumulative anthracycline dose, preparative regimen and chronic graft-versus-host disease on pulmonary and cardiac function in children 5 years after allogeneic hematopoietic stem cell transplantation: a prospective evaluation on behalf of the EBMT Pediatric Diseases and Late Effects Working Parties. Uderzo C, Pillon M, Corti P, Tridello G, Tana F, Zintl F, Nysom K, Galambrun C, Fagioli F, Varotto S, Messina C, Verdeguer A, Urban C, Faraci M, Dini G, Fedeli S, Tichelli A, Rovelli A, Socié G. Bone Marrow Transplant; 2007 Jun 15; 39(11):667-75. PubMed ID: 17401396 [Abstract] [Full Text] [Related]
35. Neurocognitive outcomes in pediatric hematological cancer survivors post-HSCT: A systematic review. Ansari S, Garg A, Khan MA. Clin Transplant; 2024 Jan 15; 38(1):e15193. PubMed ID: 37964657 [Abstract] [Full Text] [Related]
36. [Comparison of autologous and allogeneic hematopoietic stem cell transplantation for 140 patients with de novo acute leukemia in first complete remission]. Wang HH, Feng SZ, Wang M, Wei JL, Jiang EL, Zhang L, Huang Y, Zhou SY, Liu QG, Qiu LG, Han MZ, Yan WW. Zhonghua Xue Ye Xue Za Zhi; 2004 Jul 15; 25(7):389-92. PubMed ID: 15355688 [Abstract] [Full Text] [Related]